Altimmune
ALT
32 hedge funds and large institutions have $38M invested in Altimmune in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 3 closing their positions.
20,725% more call options, than puts
Call options by funds: $833K | Put options by funds: $4K
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
6% less funds holding
Funds holding: 34 → 32 (-2)
26% less capital invested
Capital invested by funds: $51.1M → $38M (-$13.1M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$948K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$559K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$512K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$128K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$51.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.02M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$17.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$6.63K |
| 5 |
Goldman Sachs
New York
|
-$3.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LYV
26
Live Your Vision
West Conshohocken,
Pennsylvania
| $10K | +$12.3K | +26 | New |
|
27
Group One Trading
Chicago,
Illinois
| $9K | +$7.11K | +15 | +214% |
|
28
Citigroup
New York
| $3K | – | – | – |
|
29
Morgan Stanley
New York
| $3K | – | – | – |
|
|
30
UBS Group
Zurich,
Switzerland
| $1K | -$17.1K | -36 | -97% |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
32
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3 | – | – | – |
|
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$18K | -34 | Closed |
|
|
AIG
34
American International Group
New York
| – | -$540 | -1 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$474 | -1 | Closed |
|
ALT Hedge Fund Activity: Q3 2015 in Review
32 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2015, worth a combined $38M — down 26% from $51.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ALT and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 11 added.
The largest buyer was Visium Asset Management, adding an estimated $948K. The largest seller was Hudson Bay Capital Management, cutting an estimated $1.02M.
- 32 institutional investors held Altimmune (ALT) as of Q3 2015, down from 34 in Q2 2015.
- Funds reported $38M of Altimmune stock for Q3 2015, down 26% quarter-over-quarter.
- 2 funds opened new Altimmune positions in Q3 2015 and 3 closed out, a net change of -1 holder.
- The largest Altimmune buyer in Q3 2015 was Visium Asset Management, an estimated $948K added.
- The largest Altimmune seller in Q3 2015 was Hudson Bay Capital Management, an estimated $1.02M sold.
Based on aggregated 13F filings for Q3 2015.